Even though the majority of attendees were immunized, a COVID-19 epidemic occurred at a conference convened by the Centers for Disease Control and Prevention (CDC) of the United States.

In April, over 1,800 CDC employees and others gathered at a hotel in Atlanta, where the CDC is headquartered, to discuss epidemiological research and strategies.

On April 27, the concluding day of the conference, several participants informed organizers that they had tested positive for COVID-19. The CDC and the Georgia Department of Public Health conducted a survey of registrants in an effort to ascertain the proportion of visitors who had tested positive.

The CDC announced on May 26 that the study aimed to “learn more about the transmission that occurred and add to our understanding as we transition to the next phase of COVID-19 surveillance and response.”

Approximately 80% of participants completed the survey. 181 of them reported positive COVID-19 test results.

99.4% of respondents reported having received at least one COVID-19 vaccination dose.

If any individuals who were not vaccinated became ill, the number of cases was not made public. In addition, no distinction was made between those who had received the most recent bivalent vaccinations and those who had not. The Centers for Disease Control and Prevention have not responded to requests for additional information.

The survey was completed by approximately 360 individuals, indicating that the outbreak may have been more pervasive.

The symposium was a “superspreader event,” according to Dr. Eric Topol, director of the Scripps Research Translational Institute, who tweeted the relevant information.

According to Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, the outbreak proves that COVID-19 is “still capable of causing large outbreaks and infecting many.”

The Georgia Department of Public Health informed The Epoch Times via email that the majority of conference attendees were non-Georgians and that many of them conducted testing at home.

The CDC stated that the survey results “underline the importance of vaccination for protecting individuals against severe illness and death related to COVID-19” because none of the respondents who reported being positive reported hospitalization.

Despite being initially approved nine months ago, the bivalent vaccines have not yet undertaken any clinical trials. Observational data indicate they provide minimal protection against infection, despite claims by authorities that they protect against severe illness. Even studies published by the CDC without peer review indicate that this protection is temporary.

The Pfizer and Moderna bivalent COVID-19 vaccinations, which supplanted the previous vaccines earlier this year, were ineffective against hospitalization, according to the most recent study, published on May 26.

Between seven and 59 days, the protection among individuals without “documented immunocompromised conditions” was 62%, but between 59 and 120 days, it fell to 47% before rising to 24%.

More on this story via The Republic Brief:

The effectiveness peaked at just 41% among people with “documented immunocompromising conditions,” dropping to 13% after 120 days. CONTINUE READING…